Resultaten visas 1 - 10 / 10433
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?

Referentgranskad
Öppen tillgång
DOI
10.1177/10732748221121383
Flander, Louisa; Dekker, Evelien; Andersen, Berit; Larsen, Mette Bach; Steele, Robert J.; Malila, Ne...
Cancer Control2022Publicationer information ikon

Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Referentgranskad
DOI
10.1002/cncr.33254
Pakarainen, Tomi;Pakarainen, Tomi;Nevalainen, Jaakko;Talala, Kirsi;Taari, Kimmo;Raitanen, Jani;Raita...
Cancer2020Publicationer information ikon

Breast cancer screening and immigrant women—A scoping review of attendance, knowledge, barriers and facilitators

Referentgranskad
Öppen tillgång
DOI
10.1002/nop2.1865
Dumky, Hanna; Fridell, Kent; Leifland, Karin; Metsälä, Eija
Nursing open2023Publicationer information ikon

The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe

Referentgranskad
Öppen tillgång
DOI
10.1097/LGT.0000000000000677
Carcopino, Xavier; Cruickshank, Maggie; Leeson, Simon; Redman, Charles; Nieminen, Pekka
Journal of lower genital tract disease2022Publicationer information ikon

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

Referentgranskad
Öppen tillgång
DOI
10.1007/s10552-021-01480-8
Walter, S. D.; Hu, Jiarui; Talala, Kirsi; Tammela, Teuvo; Taari, Kimmo; Auvinen, Anssi
Cancer causes and control2021Publicationer information ikon

Spillover improved survival in non-invited patients of the colorectal cancer screening programme

Referentgranskad
DOI
10.1177/0969141317718220
Miettinen, Joonas; Malila, Nea; Hakama, Matti; Pitkäniemi, Janne
Journal of medical screening2017Publicationer information ikon

Prognostic index for predicting prostate cancer survival in a randomized screening trial: Development and validation

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers13030435
Neupane, Subas; Nevalainen, Jaakko; Raitanen, Jani; Talala, Kirsi; Kujala, Paula; Taari, Kimmo; Tamm...
Cancers2021Publicationer information ikon

Screening for Cervical Cancer

Referentgranskad
DOI
10.1007/978-1-4614-5586-8_15
Hakama Matti
Statistics for Biology and Health2013Publicationer information ikon

Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer

Referentgranskad
Öppen tillgång
DOI
10.1002/cam4.3181
Talala, Kirsi; Heinävaara, Sirpa; Taari, Kimmo; Tammela, Teuvo L. J.; Kujala, Paula; Stenman, Ulf-Ha...
Cancer medicine2020Publicationer information ikon

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

Referentgranskad
Öppen tillgång
DOI
10.1016/j.eururo.2019.02.009
Hugosson, J.;Roobol, M.J.;Månsson, M.;Tammela, T.L.J.;Zappa, M.;Nelen, V.;Kwiatkowski, M.;Lujan, M.;...
European urology2019

What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?

Referentgranskad
Öppen tillgång
DOI
10.1177/10732748221121383
2022

Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Referentgranskad
DOI
10.1002/cncr.33254
2020

Breast cancer screening and immigrant women—A scoping review of attendance, knowledge, barriers and facilitators

Referentgranskad
Öppen tillgång
DOI
10.1002/nop2.1865
2023

The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe

Referentgranskad
Öppen tillgång
DOI
10.1097/LGT.0000000000000677
2022

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

Referentgranskad
Öppen tillgång
DOI
10.1007/s10552-021-01480-8
2021

Spillover improved survival in non-invited patients of the colorectal cancer screening programme

Referentgranskad
DOI
10.1177/0969141317718220
2017

Prognostic index for predicting prostate cancer survival in a randomized screening trial: Development and validation

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers13030435
2021

Screening for Cervical Cancer

Referentgranskad
DOI
10.1007/978-1-4614-5586-8_15
2013

Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer

Referentgranskad
Öppen tillgång
DOI
10.1002/cam4.3181
2020

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

Referentgranskad
Öppen tillgång
DOI
10.1016/j.eururo.2019.02.009
2019